ImmuCell Corporation is a growing animal health company that develops, manufactures and markets scientifically proven products that improve health and productivity in the dairy and beef industries.

They are dedicated in providing cost-effective solutions to dairy and beef producers to maximize the health and welfare of their respective productive assets – their dairy and beef calves, and their milk producing cows.

ImmuCell’s products are designed to treat infections in calves and cows without the use of traditional antibiotics used in human healthcare, thereby reducing the amount of antibiotics in the human food chain, that have given rise to incidents of life-threatening human infections from antibiotic-resistant bacteria, commonly known as “superbugs.” ImmuCell’s products play an important role in addressing this critical human health issue.

The First Defense® product line provides “immediate immunity” against aggressive pathogens, including E. coli, coronavirus and rotavirus in newborn dairy and beef calves, without the use of traditional antibiotics. First Defense utilizes proprietary vaccine and milk protein purification technologies to protect newborn dairy and beef calves against bovine enteritis (calf scours), which causes diarrhea and dehydration in newborn calves and often leads to serious sickness and even death.
ImmuCell holds a unique position…they are the only animal health company with the ability to concentrate, purify and quantify specific colostrum antibodies (E. coli, coronavirus and rotavirus) on a commercial scale. This reduces the amount of antibiotics in the human food chain and maximizes the productive capabilities of dairy and beef producers’ future operating assets – their newborn calves.

Top of Page